ABIONYX Pharma SA (EPA: ABNX)

ABIONYX Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	43	41	48	68	24	7
Market Cap Growth	7.12%	-14.37%	-28.38%	178.53%	229.66%	-20.28%
Enterprise Value	41	44	49	63	17	-1
Last Close Price	1.24	1.29	1.72	2.44	0.99	0.34
PE Ratio	-	-	-	-	-	3.98
PS Ratio	8.00	8.94	9.23	100.22	-	-
PB Ratio	4.25	5.24	6.76	6.34	3.66	1.11
P/TBV Ratio	9.39	16.83	28.22	12.95	3.69	1.11
EV/Sales Ratio	8.40	9.45	9.31	93.31	-	-
Debt / Equity Ratio	0.34	0.43	0.56	0.46	0.00	0.18
Asset Turnover	0.33	0.30	0.28	0.04	-	-
Inventory Turnover	21.80	21.86	28.49	-	-	-
Quick Ratio	2.17	1.68	1.39	1.86	2.78	2.91
Current Ratio	2.28	1.75	1.49	1.93	2.79	2.92
Return on Equity (ROE)	-47.16%	-46.62%	-47.14%	-67.28%	-28.37%	35.21%
Return on Assets (ROA)	-14.12%	-13.91%	-13.64%	-23.16%	-18.06%	-13.50%
Return on Capital (ROIC)	-19.04%	-18.96%	-19.15%	-33.38%	-25.58%	-18.36%
Earnings Yield	-8.65%	-8.48%	-8.68%	-8.61%	-7.77%	25.10%
FCF Yield	-7.20%	-9.16%	-7.27%	-10.14%	-2.89%	-53.61%
Buyback Yield / Dilution	-11.19%	-4.94%	-12.41%	-5.92%	-11.21%	-13.65%
Total Shareholder Return	-11.19%	-4.94%	-12.41%	-5.92%	-11.21%	-13.65%

Source: S&P Capital IQ. Standard template. Financial Sources.